Sonoran Biosciences is a privately held early stage pharmaceutical company that has developed SB Gel, the first viscous sustained release carrier. SB Gel enables sustained release of a wide variety of pharmaceuticals to new sites in the body, including joints, device surfaces, and healing tissues. We develop new formulations using approved active ingredients, requiring reduced development cost and risk via the 505(b)(2) approval pathway while retaining the exclusivity of a typical pharmaceutical. Formulations based on SB Gel have potential in a number of indications including deep infection, pain management, and wound healing. Our first product, SB Gel with tobramycin, is being developed for treatment of prosthetic joint infection in a one-stage surgical approach.

About Us

Our Team

Sonoran Biosciences  |  1475 N. Scottsdale Rd. Suite 200  |  Scottsdale, AZ 85257  |  P: 480-389-6413

© 2016 Sonoran Biosciences, Inc.

Derek Overstreet, PhD
Dr. Overstreet is a co-inventor of the SB Gel technology and co-founder and Chief Scientific Officer of Sonoran Biosciences. His research on novel hydrogels for biomedical applications has been presented at various conferences including meetings of the Musculoskeletal Infection Society, Orthopaedic Research Society, Materials Research Society, Biomedical Engineering Society, and the Society for Biomaterials.

Joseph Cooper,  MBA
Mr. Cooper is Interim Chief Executive Officer of Sonoran Biosciences. He is also President of Boulder Cove, LC, and operational a strategic consulting firm serving the pharmaceutical industry. Mr. Cooper is an experienced pharmaceutical executive with a background in general management, corporate development, product development and manufacturing. Mr. Cooper previously served as Executive Vice President for Medicis Pharmaceutical Corporation and in senior roles with Schein Pharmaceutical, Smith and Nephew, and GD Searle.

Alex McLaren, MD
Dr. McLaren is a co-inventor of the SB Gel technology and a Board Member of Sonoran Biosciences. He is the Director of the Orthopaedic Surgery Residency at Banner Good Samaritan Medical Center - Phoenix and is a past President and current Executive Board Member of the Musculoskeletal Infection Society (MSIS). With over 25 years of clinical experience focused on orthopaedic infections and an equal length of time in research related to antibiotic delivery and implant infections, Dr. McLaren is one of a very small number of people that has expertise both in the biology of infection and orthopaedic surgery.

Brent Vernon, PhD
Dr. Vernon is a co
-inventor of the SB Gel technology and a Board Member of Sonoran Biosciences. He is an Associate Professor of Biomedical Engineering at Arizona State University, having published over 40 peer-reviewed journal articles in the area of biomaterial development for drug delivery and tissue reconstruction. He has 20 years of academic research experience in the field of injectable polymer-based biomaterials.

Ryan McLemore, PhD
Dr. McLemore
is a co-inventor of the SB Gel technology and a Board Member of Sonoran Biosciences. As Director of Research for the orthopaedic surgery training program at Banner Good Samaritan Medical Center Phoenix, Dr. McLemore authored over 20 peer-reviewed research manuscripts and 3 book chapters, with expertise in orthopaedic biomaterials, drug delivery. He has also served as a biostatistician at Mayo Clinic Arizona.